Latest Insider Transactions at Kemper Corp (KMPR)
This section provides a real-time view of insider transactions for Kemper Corp (KMPR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of KEMPER Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of KEMPER Corp's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 07
2022
|
Robert Joseph Joyce Director |
SELL
Open market or private sale
|
Direct |
4,000
-16.74%
|
$220,000
$55.76 P/Share
|
Nov 07
2022
|
Robert Joseph Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+14.34%
|
$128,000
$32.4 P/Share
|
Aug 04
2022
|
Stuart B. Parker Director |
BUY
Open market or private purchase
|
Direct |
5,000
+12.43%
|
$210,000
$42.55 P/Share
|
Aug 03
2022
|
Jason N Gorevic Director |
BUY
Open market or private purchase
|
Direct |
3,000
+19.82%
|
$129,000
$43.0 P/Share
|
May 04
2022
|
George N Cochran Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,525
+10.05%
|
-
|
May 04
2022
|
Susan D Whiting Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,525
+20.0%
|
-
|
May 04
2022
|
Stuart B. Parker Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,525
+7.71%
|
-
|
May 04
2022
|
Robert Joseph Joyce Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,525
+11.26%
|
-
|
May 04
2022
|
Lacy M. Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,525
+17.41%
|
-
|
May 04
2022
|
Teresa Alvarez Canida Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,525
+11.96%
|
-
|
May 04
2022
|
Jason N Gorevic Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,525
+21.65%
|
-
|
May 04
2022
|
Gerald Laderman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,525
+28.93%
|
-
|
May 04
2022
|
Christopher Binyon Sarofim Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,525
+13.71%
|
-
|
May 04
2022
|
Kathleen M Cronin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,525
+14.49%
|
-
|
Mar 08
2022
|
David P Storch Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,248
-7.65%
|
$119,144
$53.0 P/Share
|
Mar 08
2022
|
David P Storch Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+11.99%
|
$116,000
$29.78 P/Share
|
Feb 14
2022
|
George N Cochran Director |
BUY
Open market or private purchase
|
Direct |
1,000
+4.74%
|
$50,000
$50.0 P/Share
|
Feb 02
2022
|
Jason N Gorevic Director |
BUY
Grant, award, or other acquisition
|
Direct |
614
+8.49%
|
-
|
Feb 02
2022
|
Anastasios Omiridis SVP, Deputy CFO & |
BUY
Grant, award, or other acquisition
|
Direct |
4,252
+42.71%
|
-
|
Feb 02
2022
|
Charles Tipton Brooks EVP, Operations & Systems |
SELL
Payment of exercise price or tax liability
|
Direct |
1,354
-6.0%
|
$70,408
$52.95 P/Share
|
Feb 02
2022
|
Charles Tipton Brooks EVP, Operations & Systems |
BUY
Grant, award, or other acquisition
|
Direct |
4,278
+15.95%
|
-
|
Feb 02
2022
|
Joseph P Lacher Jr President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,301
-7.95%
|
$535,652
$52.95 P/Share
|
Feb 02
2022
|
Joseph P Lacher Jr President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
29,508
+18.55%
|
-
|
Feb 02
2022
|
Carl Thomas Evans Jr. EVP, Sec. & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,284
-9.86%
|
$66,768
$52.95 P/Share
|
Feb 02
2022
|
Carl Thomas Evans Jr. EVP, Sec. & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,040
+23.68%
|
-
|
Feb 02
2022
|
Duane A. Sanders EVP, Property & Casualty |
SELL
Payment of exercise price or tax liability
|
Direct |
1,817
-7.51%
|
$94,484
$52.95 P/Share
|
Feb 02
2022
|
Duane A. Sanders EVP, Property & Casualty |
BUY
Grant, award, or other acquisition
|
Direct |
7,082
+22.64%
|
-
|
Feb 02
2022
|
James J. Mc Kinney EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,083
-4.5%
|
$108,316
$52.95 P/Share
|
Feb 02
2022
|
James J. Mc Kinney EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
6,786
+12.8%
|
-
|
Feb 02
2022
|
John Michael Boschelli EVP & Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,663
-8.27%
|
$86,476
$52.95 P/Share
|
Feb 02
2022
|
John Michael Boschelli EVP & Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,312
+20.9%
|
-
|
Dec 30
2021
|
Ismat Aziz EVP, CHRO & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,402
-30.61%
|
$139,316
$58.4 P/Share
|
Dec 10
2021
|
George N Cochran Director |
BUY
Open market or private purchase
|
Direct |
1,000
+4.98%
|
$52,000
$52.68 P/Share
|
Nov 26
2021
|
Robert Joseph Joyce Director |
BUY
Open market or private purchase
|
Direct |
500
+2.8%
|
$28,500
$57.71 P/Share
|
Nov 22
2021
|
Anastasios Omiridis SVP, Deputy CFO & |
SELL
Open market or private sale
|
Direct |
800
-39.06%
|
$47,200
$59.71 P/Share
|
Oct 01
2021
|
Anastasios Omiridis SVP, Deputy CFO & |
SELL
Payment of exercise price or tax liability
|
Direct |
203
-9.02%
|
$13,804
$68.24 P/Share
|
Sep 09
2021
|
George N Cochran Director |
BUY
Open market or private purchase
|
Direct |
1,500
+4.04%
|
$99,000
$66.25 P/Share
|
Aug 11
2021
|
Robert Joseph Joyce Director |
BUY
Open market or private purchase
|
Direct |
250
+1.46%
|
$16,750
$67.0 P/Share
|
Aug 06
2021
|
Robert Joseph Joyce Director |
BUY
Open market or private purchase
|
Direct |
250
+1.48%
|
$16,250
$65.36 P/Share
|
Aug 04
2021
|
Stuart B. Parker Director |
BUY
Open market or private purchase
|
Direct |
25,000
+47.44%
|
$1,525,000
$61.62 P/Share
|
May 07
2021
|
John Michael Boschelli EVP & Chief Investment Officer |
SELL
Open market or private sale
|
Direct |
7,781
-34.47%
|
$614,699
$79.07 P/Share
|
May 06
2021
|
John Michael Boschelli EVP & Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,048
-19.79%
|
$872,792
$79.46 P/Share
|
May 06
2021
|
John Michael Boschelli EVP & Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,543
+19.56%
|
$690,693
$51.65 P/Share
|
May 05
2021
|
Gerald Laderman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,670
+31.23%
|
-
|
May 05
2021
|
David P Storch Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,670
+6.18%
|
-
|
May 05
2021
|
Robert Joseph Joyce Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,670
+9.26%
|
-
|
May 05
2021
|
Stuart B. Parker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,670
+38.27%
|
-
|
May 05
2021
|
Christopher Binyon Sarofim Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,670
+11.1%
|
-
|
May 05
2021
|
Lacy M. Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,670
+15.01%
|
-
|
May 05
2021
|
Teresa Alvarez Canida Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,670
+9.42%
|
-
|